Researchers assessed whether using bispecific antibodies targeting CD20 and CD3 would reduce efficacy or increase toxicity in patients with relapsed or refractory non-Hodgkin B-cell lymphomas ...

Democratic Party primary challengers for House seats on Long Island are dropping faster than spring temperatures. Over the ...

USC researchers are developing a computational model that combines satellite data and physics-based simulations to forecast a ...

Fapon Biopharma, a clinical-stage biotech company innovating therapeutic antibodies and fusion proteins, is pleased to announce its participation in the AACR Annual Meeting 2026, taking place April 19 ...

Abogen, a clinical-stage biotechnology company focused on RNA innovation, today announced preliminary clinical results from the first-in-human (FIH) study of ABO2203 in patients with ...

The takeover – which, if completed, will be the third acquisition for UCB this decade – involves an upfront payment of $650 ...

MP0632 nominated as first logic-gated Switch-DARPin T cell engager candidate for the treatment of MSLN/EpCAM expressing solid tumors, with ...

Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) , a leading innovative, commercial-stage global biotech company ...

Two squirts of a nasal spray, and aged mice started remembering things they had forgotten. That is the headline result from a ...

This review argues that neurodegeneration is shaped not only by toxic protein buildup but also by immune signaling, with ...

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana”), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, announces the ...

Zai Lab will supply zoci while Boehringer Ingelheim will manage operations, with both companies retaining rights to their ...